Active Ingredients (In Each Immediate-Release Tablet)
Guaifenesin 400 mg
Phenylephrine HCl 10 mg
The following Structured Product Label (SPL) was submitted to the FDA by Preferred Pharmaceuticals, Inc. for the product Sinus Congestion Pe (NDC 68788-0845). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredients (in each immediate-release tablet), purpose, uses, do not use, ask a doctor before use if you have, when using this product, stop use and ask a doctor if, if pregnant or breast-feeding,, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Guaifenesin 400 mg
Phenylephrine HCl 10 mg
Expectorant
Nasal decongestant
If you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.
do not exceed recommended dosage.
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away.
hypromellose, magnesium stearate, maltodextrin, microcrystalline cellulose, polyethylene glycol, povidone, silicon dioxide, sodium starch glycolate, stearic acid
MAJOR®
NDC 68788-0845
Mucus Relief
Sinus
Guaifenesin 400 mg /
Phenylephrine HCl 10 mg
Expectorant / Nasal Decongestant
Immediate
Release
TAMPER EVIDENT: DO NOT USE IF IMPRINTED SAFETY SEAL UNDER CAP IS BROKEN OR MISSING
50844 REV0612D54201
Distributed by Major Pharmaceuticals
31778 Enterprise Drive, Livonia, MI 48150 USA
Rev. 12/14 M-17 Re-order No. 006474
Repackaged By: Preferred Pharmaceuticals Inc.
* Please review the disclaimer below.